Active, not recruitingPHASE1, PHASE2NCT06570941

Benefits of a Cannabidiolic Acid Topical Cream for the Treatment of Restless Leg Syndrome

Studying Macrocephaly-intellectual disability-neurodevelopmental disorder-small thorax syndrome

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Synthonics Inc
Intervention
Chylobinoid Topical Cream(drug)
Enrollment
10 target
Eligibility
21 years · All sexes
Timeline
20242024

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06570941 on ClinicalTrials.gov

Other trials for Macrocephaly-intellectual disability-neurodevelopmental disorder-small thorax syndrome

Additional recruiting or active studies for the same condition.

See all trials for Macrocephaly-intellectual disability-neurodevelopmental disorder-small thorax syndrome

← Back to all trials